Skip to main content
. Author manuscript; available in PMC: 2010 Nov 13.
Published in final edited form as: Prog Neuropsychopharmacol Biol Psychiatry. 2009 Jul 10;33(8):1291–1308. doi: 10.1016/j.pnpbp.2009.06.022

Figure 4.

Figure 4

The selective CRF-R1 antagonist did not disrupt, but modestly enhanced at the intermediate dose, fear-potentiated startle to a 3.7-sec CS (significant quadratic trend). Rats were trained with either normal (20 × 0.4 mA footshocks) or weak (10 × 0.25 mA footshocks) training procedures. Data from Walker et al. (2008).